Company: Cipla Ltd.
Generic Drug: Levosalbutamol + Ipratropium.
Indication: It is indicated for the treatment or prevention of bronchospasm associated with reversible obstructive airway diseases like asthma and COPD, chronic bronchitis and emphysema.
Contraindication: Hypersensitivity to preparation. Not recommended for children less than 4 years of age.
Dosage & Administration: Available as dry powder for inhalation. Rotacaps should be used by Rotahaler/ Revolizer device. Not for swallow.
- Cautious use in case of cardiovascular disorders.
- Cautious use in case of lactation & pregnancy.
- Caution use in patients with narrow-angle glaucoma and prostatic hypertrophy.
- Cautious use in case of concomitant beta blockers, diuretics, digoxin, tricyclic antidepressant and anticholinergic agents because of drug interactions.
Side effects/ Undesired effects/ Adverse drug reactions: Tremor, nervousness, hypokalemia, dry mouth, tachycardia, dizziness, headache, dysphonia, throat irritation, nausea, vomiting, sweating, urinary retention, arrhythmia, and anaphylactic reactions. Rarely paradoxical bronchoconstriction may occur.